We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-24.72%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
–
AUM
$1.73M
AUM Growth
-$678K
Cap. Flow
-$59.2K
Cap. Flow %
-3.42%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
LUNG icon
Pulmonx
LUNG
+$59.2K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WHWK
1
Whitehawk Therapeutics
WHWK
$209M
$644K 37.25%
26,666
– –
SYBX
2
DELISTED
Synlogic
SYBX
$498K 28.8%
13,727
– –
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
$435K 25.16%
375,000
– –
LUNG icon
4
Pulmonx
LUNG
$79.4M
$93K 5.38%
2,901
-1,620
-36% -$59.2K
ACGN
5
DELISTED
Aceragen Inc
ACGN
$32K 1.85%
3,312
– –
NBRV
6
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$27K 1.56%
1,834
– –

Similar funds

FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
SNN
Shen Neil Nanpeng $36.3K AUM 179.45% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
MI
Motiv8 Investments Port St. Lucie, Florida $183K AUM 15.06% 1-Year Est. Return
FFVM
Founders Fund VII Management San Francisco, California $2.03M AUM 72.34% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
NA
Newport Asia San Francisco, California $2.21M AUM
IVSFI
IA Venture Strategies Fund II New York $4.08M AUM 174.71% 1-Year Est. Return

ABG Innovation Capital Partners III's Q4 2021 Portfolio in Review

As of Q4 2021, ABG Innovation Capital Partners III held 6 positions worth $1.73M, down 28% from $2.41M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

ABG Innovation Capital Partners III withdrew a net $59.2K in Q4 2021, reducing 1 holding. Its largest reduction was Pulmonx, cutting an estimated $59.2K.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III's biggest Q4 2021 reduction was Pulmonx, cutting an estimated $59.2K.
  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $1.73M portfolio in Q4 2021.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q4 2021.
  • ABG Innovation Capital Partners III's portfolio value fell 28% quarter-over-quarter to $1.73M.

Based on ABG Innovation Capital Partners III's 13F filing for Q4 2021, filed 14 Feb 2022.